MAP2K7 and ovarian cancer: Instead, the concurrent activation of multiple signaling pathways, including PI3K/AKT/mTOR, SRC, MEK/MAPK, and JAK/STAT3, appears to be more common in ovarian cancer and may play an important role in ovarian tumor growth [9,13,14,15].